Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9NZJ9
UPID:
NUDT4_HUMAN
Alternative names:
Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 2; Nucleoside diphosphate-linked moiety X motif 4
Alternative UPACC:
Q9NZJ9; B7Z916; Q4AEJ6; Q53EZ2; Q68DD7; Q9NPC5; Q9NS30; Q9NZK0; Q9NZK1
Background:
Diphosphoinositol polyphosphate phosphohydrolase 2, also known as Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 2 or Nucleoside diphosphate-linked moiety X motif 4, is a crucial enzyme in signal transduction. It specializes in cleaving beta-phosphate from diphosphate groups in various phosphoinositides and hydrolyzing diadenosine hexaphosphate (Ap6A), yielding significant products like ADP. This protein's ability to bind U8 snoRNA, despite not playing a role in U8 snoRNA decapping activity, highlights its multifaceted biological functions.
Therapeutic significance:
Understanding the role of Diphosphoinositol polyphosphate phosphohydrolase 2 could open doors to potential therapeutic strategies.